www.biomedcentral.com

Table 5
Predictive abilities for cross-validation within (W) or between (B) families for behavioural and physiological traits
Trait¹	TA		TF		FB		HC		I75
Model²	W³	B⁴	W⁵	B⁶	W⁵	B⁶	W³	B⁷	W³	B⁴
(1)	0.37	0.16	0.29	−0.04	0.21	0.10	0.33	0.08	0.42	0.08
(2) 100%	0.43	0.34	0.31	0.19	0.22	0.11	0.33	0.05	0.42	0.13
(2) 70%	0.43	0.34	0.31	0.18	0.22	0.12	0.33	0.05	0.42	0.13
(2) 40%	0.43	0.35	0.32	0.19	0.22	0.11	0.33	0.05	0.42	0.13
(2) 10%	0.42	0.34	0.33	0.20	0.21	0.11	0.33	0.06	0.42	0.14
(2) 7.5%	0.42	0.33	0.32	0.20	0.21	0.11	0.33	0.06	0.42	0.14
(2) 5%	0.41	0.30	0.32	0.19	0.21	0.11	0.33	0.06	0.42	0.13
(2) 2.5%	0.40	0.27	0.31	0.18	0.20	0.10	0.33	0.06	0.42	0.12
(3) 100%	0.43	0.33	0.33	0.17	0.22	0.13	0.33	0.06	0.43	0.13
(3) 70%	0.43	0.34	0.33	0.17	0.22	0.12	0.33	0.05	0.43	0.13
(3) 40%	0.43	0.34	0.33	0.17	0.22	0.12	0.33	0.05	0.43	0.13
(3) 10%	0.42	0.33	0.34	0.19	0.22	0.12	0.33	0.06	0.43	0.13
(3) 7.5%	0.42	0.32	0.34	0.18	0.22	0.12	0.33	0.07	0.43	0.13
(3) 5%	0.42	0.30	0.34	0.17	0.22	0.12	0.33	0.07	0.43	0.14
(3) 2.5%	0.41	0.28	0.33	0.16	0.21	0.12	0.33	0.08	0.43	0.12

1. Trait: TA = Total activity in open field test; TF = Time freezing during cue; FB = Fecal boli after cue; HC = Hematocrit percentage; I75 = Insulin level.

2. Model: (1) = polygenic; (2) = genomic; (3) = polygenic and genomic; with 100/10/2.5% of the markers allowed to have an effect.

3. W: cross-validation within families (all s.e. ≤ 0.01).

4. B: cross-validation between families (all s.e. ≤ 0.03).

5. W: cross-validation within families (all s.e. ≤ 0.02).

6. B: cross-validation between families (all s.e. ≤ 0.04).

7. B: cross-validation between families (all s.e. ≤ 0.02).

Kapell et al. BMC Genetics 2012 13:42 doi:10.1186/1471-2156-13-42

Table 5